Put Options

8 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$78.36 - $124.66 $21.6 Million - $34.4 Million
275,800 Added 13133.33%
277,900 $33 Million
Q2 2024

Aug 13, 2024

SELL
$80.36 - $102.87 $522,340 - $668,655
-6,500 Reduced 75.58%
2,100 $168,000
Q1 2024

May 09, 2024

BUY
$88.96 - $112.35 $765,056 - $966,210
8,600 New
8,600 $793,000
Q1 2022

May 11, 2022

SELL
$126.25 - $231.85 $1.01 Million - $1.85 Million
-8,000 Reduced 2.23%
351,500 $60 Million
Q4 2021

Feb 10, 2022

SELL
$216.64 - $362.52 $13.3 Million - $22.3 Million
-61,500 Reduced 14.61%
359,500 $92.7 Million
Q3 2021

Nov 12, 2021

SELL
$205.93 - $447.23 $11 Million - $23.8 Million
-53,300 Reduced 11.24%
421,000 $115 Million
Q2 2021

Aug 12, 2021

BUY
$113.32 - $241.49 $11.7 Million - $24.9 Million
103,200 Added 27.81%
474,300 $106 Million
Q1 2021

May 17, 2021

BUY
$85.73 - $119.5 $31.8 Million - $44.3 Million
371,100 New
371,100 $40.5 Million

Others Institutions Holding BNTX

About BioNTech SE


  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $28B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Twin Tree Management, LP Portfolio

Follow Twin Tree Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Tree Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Twin Tree Management, LP with notifications on news.